These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Performance comparison: exome sequencing as a single test replacing Sanger sequencing. Fridman H; Bormans C; Einhorn M; Au D; Bormans A; Porat Y; Sanchez LF; Manning B; Levy-Lahad E; Behar DM Mol Genet Genomics; 2021 May; 296(3):653-663. PubMed ID: 33694043 [TBL] [Abstract][Full Text] [Related]
4. Barcode-free next-generation sequencing error validation for ultra-rare variant detection. Yeom H; Lee Y; Ryu T; Noh J; Lee AC; Lee HB; Kang E; Song SW; Kwon S Nat Commun; 2019 Feb; 10(1):977. PubMed ID: 30816127 [TBL] [Abstract][Full Text] [Related]
5. A comprehensive assessment of Next-Generation Sequencing variants validation using a secondary technology. Zheng J; Zhang H; Banerjee S; Li Y; Zhou J; Yang Q; Tan X; Han P; Fu Q; Cui X; Yuan Y; Zhang M; Shen R; Song H; Zhang X; Zhao L; Peng Z; Wang W; Yin Y Mol Genet Genomic Med; 2019 Jul; 7(7):e00748. PubMed ID: 31165590 [TBL] [Abstract][Full Text] [Related]
6. A machine learning model to determine the accuracy of variant calls in capture-based next generation sequencing. van den Akker J; Mishne G; Zimmer AD; Zhou AY BMC Genomics; 2018 Apr; 19(1):263. PubMed ID: 29665779 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations. Zanella I; Merola F; Biasiotto G; Archetti S; Spinelli E; Di Lorenzo D Exp Mol Pathol; 2017 Apr; 102(2):314-320. PubMed ID: 28263838 [TBL] [Abstract][Full Text] [Related]
8. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk. Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519 [TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Template-Independent Next-Generation Sequencing Assay for Detecting Low-Level Resistance-Associated Variants of Hepatitis C Virus. Wei B; Kang J; Kibukawa M; Chen L; Qiu P; Lahser F; Marton M; Levitan D J Mol Diagn; 2016 Sep; 18(5):643-656. PubMed ID: 27393904 [TBL] [Abstract][Full Text] [Related]
10. Software-Assisted Manual Review of Clinical Next-Generation Sequencing Data: An Alternative to Routine Sanger Sequencing Confirmation with Equivalent Results in >15,000 Germline DNA Screens. Muzzey D; Kash S; Johnson JI; Melroy LM; Kaleta P; Pierce KA; Ready K; Kang HP; Haas KR J Mol Diagn; 2019 Mar; 21(2):296-306. PubMed ID: 30529126 [TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing (NGS) in the microbiological world: How to make the most of your money. Vincent AT; Derome N; Boyle B; Culley AI; Charette SJ J Microbiol Methods; 2017 Jul; 138():60-71. PubMed ID: 26995332 [TBL] [Abstract][Full Text] [Related]
12. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing. Mu W; Lu HM; Chen J; Li S; Elliott AM J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647 [TBL] [Abstract][Full Text] [Related]
13. Sanger Validation of High-Throughput Sequencing in Genetic Diagnosis: Still the Best Practice? De Cario R; Kura A; Suraci S; Magi A; Volta A; Marcucci R; Gori AM; Pepe G; Giusti B; Sticchi E Front Genet; 2020; 11():592588. PubMed ID: 33343633 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants. Shin S; Hwang IS; Lee ST; Choi JR Breast Cancer Res Treat; 2016 Aug; 158(3):433-40. PubMed ID: 27383479 [TBL] [Abstract][Full Text] [Related]
15. ClinQC: a tool for quality control and cleaning of Sanger and NGS data in clinical research. Pandey RV; Pabinger S; Kriegner A; Weinhäusel A BMC Bioinformatics; 2016 Feb; 17():56. PubMed ID: 26830926 [TBL] [Abstract][Full Text] [Related]
16. Performance evaluation of an amplicon-based next-generation sequencing panel for BRCA1 and BRCA2 variant detection. Park K; Kim MK; Lee T; Hong J; Kim HK; Ahn S; Lee YJ; Kim J; Lee SW; Lee JW; Lee W; Chun S; Son BH; Jung KH; Kim YM; Min WK; Ahn SH J Clin Lab Anal; 2020 Dec; 34(12):e23524. PubMed ID: 32812259 [TBL] [Abstract][Full Text] [Related]
17. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels. LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038 [TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients. Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243 [TBL] [Abstract][Full Text] [Related]
19. Assessing the necessity of confirmatory testing for exome-sequencing results in a clinical molecular diagnostic laboratory. Strom SP; Lee H; Das K; Vilain E; Nelson SF; Grody WW; Deignan JL Genet Med; 2014 Jul; 16(7):510-5. PubMed ID: 24406459 [TBL] [Abstract][Full Text] [Related]
20. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis. Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]